ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 5.94
-0.17 (-2.78%)
Apr 17, 2026, 4:08 PM HKT
17.62% (1Y)
| Market Cap | 2.64B +37.4% |
| Revenue (ttm) | 171.70M +94.0% |
| Net Income | -243.24M |
| EPS | -0.59 |
| Shares Out | 431.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,067,000 |
| Average Volume | 1,716,010 |
| Open | 6.16 |
| Previous Close | 6.11 |
| Day's Range | 5.85 - 6.28 |
| 52-Week Range | 3.43 - 16.80 |
| Beta | 0.33 |
| RSI | 63.45 |
| Earnings Date | Mar 25, 2026 |